DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

References

Gridelli C et al.
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial.

J Clin Oncol 2010;
28 Abstract 7508

Download Bibliographical Data

Search in: